Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Accounts Receivables history
Currency unavailable · from the cash flow
No Accounts Receivables data reported for this period type.
Accounts Receivables vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $13.42M USD | -2409.1% | +238.7% | 4.8% | |
| LTM Mar 2026 | $7.86M USD | +44.2% | — | 3.4% | |
| LTM Mar 2026 | $6.81M USD | +5438.2% | +253.5% | 81.4% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $0 USD | — | — | — |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | — | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +44.2% | +246.1% | 3.4% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.